Research Archive — Page 81 of 134
-
October 13, 2020
COVID-19 long-acting antibodies discovered by Vanderbilt University Medical Center move to phase 3 clinical trials
AstraZeneca is advancing into phase 3 clinical trials with an investigational COVID-19 therapy of two long-acting antibodies discovered by Vanderbilt University Medical Center and optimized by AstraZeneca. -
October 8, 2020
Researchers create molecular ‘atlas’ of GI tract neurons
Researchers at Vanderbilt University Medical Center have generated the first comprehensive molecular “atlas” of genes expressed by the neuronal cells within the intestine that coordinate the functions of the gastrointestinal (GI) tract. -
October 7, 2020
Vanderbilt Prize winner Doudna awarded Nobel Prize in Chemistry
University of California, Berkeley, biochemist Jennifer Doudna, PhD, recipient of the 2020 Vanderbilt Prize in Biomedical Science, has been awarded the 2020 Nobel Prize in Chemistry. -
October 6, 2020
Bick receives NIH Director’s Early Independence Award
Alexander Bick, MD, PhD, a new faculty member in the Division of Genetic Medicine at Vanderbilt University Medical Center, has received a 2020 National Institutes of Health (NIH) Director’s Early Independence Award. -
October 6, 2020
Early steps in reovirus replication
Conformational change in a reovirus surface protein modulate the virus’s attachment to host cells, Vanderbilt researchers have found. -
October 5, 2020
Treating appendicitis with antibiotics instead of surgery may be good option for some, but not all, patients
Antibiotics instead of surgery may be a good choice for some, but not all, patients with appendicitis, according to results from a study reported today in the New England Journal of Medicine. -
October 5, 2020
Nominations sought for 2021 Vanderbilt Prize in Biomedical Science
Nominations for the 2021 Vanderbilt Prize in Biomedical Science are now being accepted. The nomination deadline is Dec. 11.